
Todd Petersen, CEO of VitalSkin Dermatology, covers the ins and outs of the due diligence, legal documentation and final negotiation stages of selling a practice.

Todd Petersen, CEO of VitalSkin Dermatology, covers the ins and outs of the due diligence, legal documentation and final negotiation stages of selling a practice.

In this month's article on Selling Your Practice, we discuss letter of intent (LOI), soliciting letter(s) of intent, and negotiating the material terms for a sale of your practice.

Jeremy Youse, M.D., founding partner, medical director and practicing dermatologist at VitalSkin Dermatology discusses which tasks he and other dermatologists want control over to get the most out of practicing and running their offices efficiently each day.

Jerri Ivey, director of revenue cycle management at VitalSkin Dermatology, shares details on the upcoming 2021 E&M revisions, including what changes are taking place, the why behind the revisions, and what steps you can take to prepare.

One expert offers insight into how to develop a confidential information memorandum and approach potential buyers, and when to sign non-disclosure agreements.

This month, Todd Peterson, CEO of VitalSkin Dermatology, focuses on how to identify potential buyers and perform your own initial due diligence on them before putting your practice up for sale.

Expert tips and techniques on the best ways to select, hire and retain the right people for your team.

The next two steps in the Selling Your Practice process are perhaps the most important: preparing to clearly understand what you desire from a sale of your practice, and understanding its true value on the open market.

Ashley Buehnerkemper, director of marketing at VitalSkin Dermatology, shares the essentials of managing your dermatology practice’s online reputation.

A financial pro forma is a set of financial projections used by the practice to help potential investors or creditors anticipate the financial results of the practice based on a set of assumptions. Todd Petersen shares how you put one together and whose expertise you need.

As states begin to reopen-and patients return to healthcare providers-you, your team and your patients likely have a lot of questions regarding what the post-COVID-19 healthcare experience will be like. You can take these steps to alleviate team safety concerns and communicate safety changes to patients.

Betsy Wernli, M.D., board-certified dermatologist and president of Forefront Dermatology, shares the unique ways that her practice has adapted care during the pandemic.

Read one New York physician's insights on practice survival and patient care during the pandemic.

The coronavirus has created a challenging environment for all dermatology practices. Todd Petersen, CEO of VitalSkin Dermatology, discusses how to make the most of a bad situation by using telemedicine, making plans to reopen and performing a strategic review of your practice.

Taking the time to analyze and benchmark your practice can help you both position it for sale and find the right buyer.

In this article, Todd Petersen, CEO of VitalSkin Dermatology, discusses how to protect your practice from financial impropriety in its various forms.

Todd Petersen, CEO of VitalSkin Dermatology, offers more insight into the legal and financial implications of selling your dermatology practice. In this article, he explains various types of sales structures and highlights tax considerations to keep in mind.

Mounting revenue pressure requires dermatology practices to reconsider their approach to Medicare MIPS involvement and health insurance contracting strategies, says this expert.

Todd Petersen, CEO of VitalSkin Dermatology, knows that selling a practice can be intimidating, and offers pearls to guide you through the process.

Crown Laboratories has announced business division restructuring to establish themselves in the global skin care and dermatology market.

An expert weighs in on the factors driving a growing number of dermatologists to sell their practices.

What actions should a medical practice take to protect itself from a data breach? This expert weighs in.

Eli Lilly has announced its plan to acquire Dermira, a biopharmaceutical company that specializes in developing drugs to treat a variety of skin conditions, according to a recent press release published January 10, 2010.

Leo Pharma A/S and Portal Instruments are now collaborating on a new needle-free handheld jet injector for patients that self-administer medicines for cutaneous diseases and ailments.

Managing an aesthetic or medical practice can be scary. Get tips and tricks from a seasoned pro who practices with 14 other dermatologists and nearly 100 staff members.